selected publications
- Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab. Leukemia & lymphoma. 2023 Academic Article GET IT
- Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis. Science immunology. 2023 Academic Article GET IT
- Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. RMD open. 2023 Academic Article GET IT
- 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.). 2023 Academic Article GET IT
- 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis. Arthritis care & research. 2023 Academic Article GET IT
-
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Annals of the rheumatic diseases.
2023
Academic Article
GET IT
Times cited: 17 - A "Gold Standard" in the Management of Arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2023 Academic Article GET IT
- Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group. Seminars in arthritis and rheumatism. 2022 Review GET IT
- Monitoring and Management of the Patient with Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Current Perspectives. Journal of inflammation research. 2022 Review GET IT
-
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
Journal for immunotherapy of cancer.
2022
Academic Article
GET IT
Times cited: 28 - Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
- Higher Checkpoint Inhibitor Arthritis Disease Activity may be Associated With Cancer Progression: Results From an Observational Registry. ACR open rheumatology. 2020 Academic Article GET IT
-
Autoimmune complications of immunotherapy: pathophysiology and management.
BMJ (Clinical research ed.).
2020
Academic Article
GET IT
Times cited: 21 -
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
The oncologist.
2019
Review
GET IT
Times cited: 36 -
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor.
Annals of the rheumatic diseases.
2018
Article
GET IT
Times cited: 7